0001758394-18-000001.txt : 20181108 0001758394-18-000001.hdr.sgml : 20181108 20181108160335 ACCESSION NUMBER: 0001758394-18-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20181108 DATE AS OF CHANGE: 20181108 EFFECTIVENESS DATE: 20181108 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Sun Pharm Investments Ltd. CENTRAL INDEX KEY: 0001758394 IRS NUMBER: 000000000 STATE OF INCORPORATION: Z4 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-325399 FILM NUMBER: 181169628 BUSINESS ADDRESS: STREET 1: 1688 - 152ND STREET, SUITE 205 CITY: SURREY STATE: A1 ZIP: V4A 4N2 BUSINESS PHONE: 604-501-6901 MAIL ADDRESS: STREET 1: 1688 - 152ND STREET, SUITE 205 CITY: SURREY STATE: A1 ZIP: V4A 4N2 D 1 primary_doc.xml X0708 D LIVE 0001758394 Sun Pharm Investments Ltd. 1688 - 152ND STREET, SUITE 205 SURREY A1 BRITISH COLUMBIA, CANADA V4A 4N2 604-501-6901 CANADA (FEDERAL LEVEL) None None Corporation true 2017 Manoj Sikka 1688 - 152nd Street, Suite 205 Surrey A1 BRITISH COLUMBIA, CANADA V4A 4N2 Executive Officer Director Promoter Mark Catroppa 1688 - 152nd Street, Suite 205 Surrey A1 BRITISH COLUMBIA, CANADA V4A 4N2 Executive Officer Director Promoter Kevin Coft 1688 - 152nd Street, Suite 205 Surrey A1 BRITISH COLUMBIA, CANADA V4A 4N2 Executive Officer Director Other No Revenues 06b false 2018-10-24 false true false 0 422061 422061 0 U.S. dollar amounts are based on the Bank of Canada average rate of exchange reported on October 24, 2018, which was CDN$1.3029=US$1.00. false 3 0 0 0 In the ordinary course of business, the issuer may use some of the proceeds of the offering to pay salaries to certain of its executive officers and directors. false Sun Pharm Investments Ltd. Manoj Sikka Manoj Sikka Director and President 2018-11-08